Injection of unverified, unsterile compounds carries infection and inflammatory risks that are independent of any effects the peptide itself might or might not have
Another recent study presented at the American Society of Clinical Oncologists meeting in June, showed both bariatric surgery and GLP-1 medications dramatically reduce the risk of the 13 obesity-related cancers
Although no official approval date has been announced, many industry analysts expect it could become available after successful completion of these trials and FDA review, potentially in 2027
While heartburn can be bothersome, it is typically manageable through dietary modifications, lifestyle adjustments, and when necessary, acid-suppressing medications
In Part 3, we outlined reasons for optimism that the impacts of incretin-based therapies could exceed those assumed in our central scenario largely due to their emerging use in treating a broader range of diseases, and potentially even in disease prevention
Theres no trial directly comparing retatrutide and Wegovy, and there isnt likely to be one before retatrutide is approved
